Christopher Murray
Chief Tech/Sci/R&D Officer at BLUEPRINT MEDICINES CORPORATION
Net worth: 3 M $ as of 2024-04-29
Christopher Murray active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 2017-10-09 | - |
Career history of Christopher Murray
Former positions of Christopher Murray
| Companies | Position | Start | End |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2013-11-30 | 2017-04-30 |
Training of Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher Murray
- Experience
